Progression of Parkinson's disease is associated with gut dysbiosis: Two-year follow-up study
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
BACKGROUND: We previously reported gut dysbiosis in patients with Parkinson's disease (PD). OBJECTIVE: The aim of this study is to examine whether gut dysbiosis correlates with the progression of PD. METHODS: We examined changes in gut microbiota and demographic features in 2 years in 36 PD patients. RESULTS: A change of total UPDRS scores in 2 years was predicted by the counts of Bifidobacterium and Atopobium cluster at year 0 with a correlation coefficient of 0.52. Correlation analysis additionally revealed that low counts of Bifidobacterium and Bacteroides fragilis at year 0 were associated with worsening of UPDRS I scores in 2 years. In addition, low counts of Bifidobacterium at year 0 were associated with worsening of hallucinations/delusions in 2 years. Similarly, low counts of B. fragilis at year 0 were associated with worsening of motivation/initiative in 2 years. The patients were evenly divided into the deteriorated and stable groups based on the degree of worsening of total UPDRS scores. The deteriorated group had lower counts of Bifidobacterium, B. fragilis, and Clostridium leptium than the stable group at year 0 but not at year 2, suggesting that the deteriorated group may demonstrate accelerated lowering of these bacteria at year 0. CONCLUSIONS: The total counts of intestinal bacterial decrease in the course of PD progression. Temporal profiles of lowering of bacterial counts are likely to be different from bacteria to bacteria, and also between the deteriorating and stable groups, which may be able to be exploited to differentiate patients with rapidly and slowly progressive PD pathology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Minato et al. 57 investigated the relationship between intestinal disorders and disease progression through a 2-year follow-up of patients with Parkinson's disease and found that the decreased abundance of Bifidobacterium and Bacteroides fragilis was related to the deterioration of the Unified Parkinson's Disease Rating Scale (UPDRS)-I score”
From The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options (2021) · cites this paper as [57]
The cited source says what the claim attributes to it.
In the citing paper
“suggesting that the gut microbiota may be seriously influenced by disease progression.57”
From The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options (2021) · cites this paper as [57]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Parkinsonism: onset, progression, and mortality
Hoehn, M. M., & Yahr, M. D. (1967) · Neurology · doi:10.1212/wnl.17.5.427 · Cited by 12,107
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777
(1996) · Institutional Research Information System University of Turin (University of Turin) · doi:10.1111/j · Cited by 5,486
Overdependence on degraded gist memory in Alzheimer's disease.
Gallo, D. A., Shahid, K. R., Olson, M. A., Solomon, T. M., Schacter, D. L., & Budson, A. E. (2006) · Neuropsychology · doi:10.1037/0894-4105.20.6.625 · Cited by 4,732
The FAB: A frontal assessment battery at bedside
Dubois, B., Slachevsky, A., Litvan, I., & Pillon, B. (2000) · Neurology · doi:10.1212/wnl.55.11.1621 · Cited by 3,913
Gut Microbiota from Twins Discordant for Obesity Modulate Metabolism in Mice
Ridaura, V. K., Faith, J. J., Rey, F. E., Cheng, J., Duncan, A. E., Kau, A. L., Griffin, N. W., Lombard, V., Henrissat, B., Bain, J. R., et al. (2013) · Science · doi:10.1126/science.1241214 · Cited by 3,788
Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease
Sampson, T. R., Debelius, J. W., Thron, T., Janssen, S., Shastri, G. G., Ilhan, Z. E., Challis, C., Schretter, C. E., Rocha, S., Gradinaru, V., et al. (2016) · Cell · doi:10.1016/j.cell.2016.11.018 · Cited by 3,622
Atopic Dermatitis: Global Epidemiology and Risk Factors
Nutten, S. (2015) · Annals of Nutrition and Metabolism · doi:10.1159/000370220 · Cited by 3,055
Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030
Dorsey, E. R., Constantinescu, R., Thompson, J. P., Biglan, K. M., Holloway, R. G., Kieburtz, K., Marshall, F. J., Ravina, B. M., Schifitto, G., Siderowf, A., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000247740.47667.03 · Cited by 2,472
The prevalence of Parkinson's disease: a systematic review and meta-analysis
Pringsheim, T., Jette, N., Frolkis, A., & Steeves, T. D. L. (2014) · Movement Disorders · doi:10.1002/mds.25945 · Cited by 2,188
Cited by
Items 201–258 of 258
Wei, H., Hu, Y., & Yang, L. (2021) · Archives of Medical Science · doi:10.5114/aoms/143780 · Cited by 4
“It was also found that patients with progressive PD showed a lower count of Bi-fidobacterium species in their fecal specimens [46], and constipation and stool consistency are associated with intestinal flora diversity and abundance of different bacteria species [47].”
Faecal microbiota transplantation: what’s beyond Clostridium difficile infection?
Tamilarasan, A. G., & Krishnananthan, T. (2020) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000001938 · Cited by 3
Manfready, R. A., Goetz, C. G., & Keshavarzian, A. (2022) · International review of neurobiology · doi:10.1016/bs.irn.2022.07.008 · Cited by 2
Wpływ mikrobioty jelitowej na występowanie zaburzeń psychicznych oraz chorób neurodegeneracyjnych
Frej−Mądrzak, M., Kołodziej, P., Sarowska, J., & Jama−Kmiecik, A. (2021) · Postępy Higieny i Medycyny Doświadczalnej · doi:10.2478/ahem-2021-0021 · Cited by 3
Microbial Metabolism of Levodopa as an Adjunct Therapeutic Target in Parkinson’s Disease
Feix, J. B., Cheng, G., Hardy, M., & Kalyanaraman, B. (2026) · Antioxidants · doi:10.3390/antiox15010120 · Cited by 3
Abdelaziz, A. M. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.116628 · Cited by 2
The Gut-Brain Axis: A Critical Link between Type 2 Diabetes and Parkinson’s disease
Almohmadi, N. H., Al‐kuraishy, H. M., Hussein, K. S., Turkistani, A., Yousef, F. M., Al-Gareeb, A. I., Abdelaziz, A. M., Elewa, Y. H. A., & Batiha, G. E. (2026) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-026-11014-w · Cited by 5
Research Progress on the Mechanism of Ginsenosides in the Treatment of Parkinson’s Disease
Wang, S., Chen, Z., Tang, H., Gong, J., Xu, K., & Wang, K. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27104544 · Cited by 2
“It has been reported that approximately 80% of PD patients experience gastrointestinal dysfunction, particularly constipation [43].”
Effects of indoxyl sulfate on dopaminergic neurons and motor functions
Oh, M., Choi, J., Ju, I. G., Huh, E., Noh, D., & Gu, P. S. (2020) · Journal of Pharmaceutical Negative Results · doi:10.4103/jpnr.jpnr_23_19 · Cited by 2
Sex Differences and Gut Microbiota Changes in Parkinson’s Disease
Lee, J., & Shin, C. M. (2022) · Springer eBooks · doi:10.1007/978-981-19-0120-1_24 · Cited by 2
The Role of Gut Microbiota in Aging-Associated Diseases
Mobed, A. (2023) · International Journal of Aging · doi:10.34172/ija.2023.e12 · Cited by 3
Gisevius, B., Haghikia, A., & Hirschberg, S. (2019) · e-Neuroforum · doi:10.1515/nf-2018-0013 · Cited by 2
“Furthermore, changes in Parkinson’s patients’ microbiome also correlate with disease progression (Minato et al., 2017): the relative abundance of Enterobacteriaceae is associated with motor dysfunction (Scheperjans et al., 2015).”
BackgroundSantos, R. B., dos Anjos, H. A., Ribeiro, T. T., & Correia, V. D. D. M. R. (2020) · Research Society and Development · doi:10.33448/rsd-v9i9.7259 · Cited by 2
Neurotensin-Binding Immunoglobulin G in Patients with Parkinson’s Disease
Muruzheva, Z. M., Egorov, D. S., Absalyamova, M. T., Traktirov, D. S., Karpenko, M. N., & Fetissov, S. O. (2022) · NeuroImmunoModulation · doi:10.1159/000527872 · Cited by 2
“The latter group was mainly represented by Fecalibacterium of the Oscillospiraceae family and by the Lachnospiraceae family, both belonging to short-chain fatty acids-producing class of Clostridia of the phylum of Firmicutes [44, 45].”
BackgroundDopaminergic Medication Accentuates Fecal Gut Microbiome Changes in Parkinson’s DiseasePreprint
Boertien, J. M., Pereira, P. A., Laine, P., Paulin, L. G., van der Zee, S., Auvinen, P., Scheperjans, F., & van Laar, T. (2022) · medRxiv · doi:10.1101/2022.12.23.22283907 · Cited by 2
wheel of microbiome rises, and it falls
Kołodziej, J., & Krzemińska, P. (2024) · Quality in Sport · doi:10.12775/qs.2024.15.53020 · Cited by 1
Gut microbiota in regulation of neuromuscular coordination
Roy, S., Chakraborty, B., & Choudhury, L. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33351-4.00024-6 · Cited by 1
Bicknell, B. T., Liebert, A. D., McLachlan, C. S., & Kiat, H. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15010368 · Cited by 1
Zhu, Y., Wang, S., Zhao, S., Zeng, Y., Li, J., Wang, P., Dou, Z., & Wang, T. (2026) · NeuroToxicology · doi:10.1016/j.neuro.2026.103401 · Cited by 1
Parkinson’s Disease: Possible Mechanisms for Nutritional Approaches
Cherpak-Castagna, C. E., & Lare, S. J. V. (2020) · Journal of Restorative Medicine · doi:10.14200/jrm.2020.0104 · Cited by 1
“correlates with motor-related symptoms,(36) and an increase in Enterobacteriaceae, which is associated with postural and gait abnormalities.(36,37) Eating foods rich in prebiotic carbohydrates such as Jerusalem artichokes, onions, garlic, leeks, dandelion greens, asparagus, chicory root, bananas, cocoa, and nuts will…”
BackgroundMicrobiota and Parkinson's disease (overview)
Tyutina, R. R., Pilipovich, A. A., Голубев, В. Л., & Danilov, A. B. (2020) · Medical alphabet · doi:10.33667/2078-5631-2020-1-10-14 · Cited by 2
“Двухлетнее исследование, в котором изучалась взаимосвязь дисбактериоза кишечника с прогрессированием БП [49], показало, что общее количество интестинальных бактерий снижается по мере прогрессирования заболевания (брался 2-летний период) (рассматривались Bifidobacterium, Bacteroides fragilis).”
Role of Gastrointestinal Dysbiosis and Fecal Transplantation in Parkinson’s Disease
Jena, R., Jain, R., Muralidharan, S., Yanamala, V. L., Zubair, Z., Kantamaneni, K., Jalla, K., Renzu, M., & Alfonso, M. (2021) · Cureus · doi:10.7759/cureus.19035 · Cited by 2
“Two long-term observational studies addressed the correlation of gut dysbiosis and the progression of PD in the patient [25,26].”
BackgroundClinical phenotypes and constipation severity in Parkinson’s disease: Relation to Prevotella species
Mekky, J. F., Ahmad, S., Metwali, M., Farouk, S., Monir, S., El-Sayed, A. M. A., & Asser, S. L. (2022) · Microbes and Infectious Diseases /Microbes and Infectious Diseases · doi:10.21608/mid.2022.110401.1218 · Cited by 4
Micronutrients and Parkinson’s Disease
Azmin, S., Rani, R. M., & Ibrahim, N. M. (2022) · Nutritional neurosciences · doi:10.1007/978-981-16-6467-0_9 · Cited by 1
Peterson, C. T., Iablokov, S. N., Rodionov, D. A., & Peterson, S. N. (2023) · Microorganisms · doi:10.3390/microorganisms11081979 · Cited by 3
Rajeev, A., & Chattopadhyay, I. (2024) · Springer eBooks · doi:10.1007/978-981-99-8803-7_13 · Cited by 1
Sharma, S., Jain, S., Chittora, R., Chaudhry, R., Nag, T. C., Elavarasi, A., Radhakrishnan, D. M., Pandey, S., Das, S., Bamola, V. D., et al. (2025) · Annals of Neurosciences · doi:10.1177/09727531251335746 · Cited by 4
“35 The gut microbiota presents a promising avenue for PD treatment, with research on the Mediterranean diet, probiotics and faecal microbial transplantation showing significant potential.”
腸内フローラ解析システムYakult Intestinal Flora-SCAN(YIF-SCAN)の開発と応用
Tsuji, H. (2018) · KAGAKU TO SEIBUTSU · doi:10.1271/kagakutoseibutsu.56.371
Self-citationEnvironmental toxicant exposure and Parkinson’s disease: LRRK2 and inflammatory processes
Dwyer, Z. (2019) · Carleton University's Institutional Repository (MacOdrum Library, Carleton University) · doi:10.22215/etd/2019-13709
“Tracking human PD patients through regular fecal samples has demonstrated that total bacterial diversity in the intestine decreases with disease progression [206].”
BackgroundBeauchamp, S. (2019) · Carleton University's Institutional Repository (MacOdrum Library, Carleton University) · doi:10.22215/etd/2019-13811
Metagenomic analysis of gut microbiota in Parkinson's disease patients from Central ChinaPreprint
Zhang, F., Zhao, Q., Fang, X., Xu, M., Tang, J., Zhang, Y., Gao, P. T., Sun, X., Sang, M., & Wang, P. (2020) · doi:10.21203/rs.2.21271/v2
The Gut Microbiome in Neurodegenerative Disorders
Euers, L. A., & Quigley, E. M. M. (2020) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780190931544.013.11 · Cited by 1
The contribution of gut microbiota in the pathogenesis of Parkinson’s disease
Farooqui, T. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821039-0.00008-3
Analysis of neurodegenerative disorders across multiple species
Eaton, S. (2021) · ERA · doi:10.7488/era/1220
Metagenomic analysis of gut microbiota in Parkinson's disease patients from Central ChinaPreprint
Zhang, F., Zhao, Q., Fang, X., Xu, M.-L., Tang, J., Zhang, Y., Gao, P., Sun, X., Sang, M., & Wang, P. (2020) · doi:10.21203/rs.2.21271/v1
“coli can lead to stress response, and the release of pro-inflammatory cytokines IL-β and IL-6, which cause increased intestinal permeability[37].”
BackgroundProbiotics and gut-brain axis modulation
de Oliveira, M. E. G. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-89908-6.00018-2 · Cited by 1
Editors, T. P. O. (2023) · PLoS ONE · doi:10.1371/journal.pone.0280116
Norouzy, A., Mohamadinarab, M., & Kalayeh, H. M. G. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-89834-8.00046-5
HUMAN MICROBIOME: VILLAIN OR HERO?
Rodrigues, A. R. D. L., de Azevedo, N. S., & do Amaral, V. (2023) · International Journal of Health Science · doi:10.22533/at.ed.1593702304095
The Effects of Gut Dysbiosis via Bacteriophages and its Role in Parkinson's Disease
Mazhar, S. F. (2023) · Carleton University's Institutional Repository (MacOdrum Library, Carleton University) · doi:10.22215/etd/2023-15758 · Cited by 1
Role of probiotics in brain health
Thakur, A. K., Shekhar, N., Tyagi, S., & Rani, S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-18951-7.00009-8
The Microbiome-Gut-Brain Axis, Nutrition and Parkinson’s Disease
Guk, J., Lokominienė, R. K., & Jatužis, D. (2024) · Neurologijos seminarai · doi:10.29014/ns.2023.27.97.8
From Gut to Brain: Targeting Probiotics in Neurodegenerative Health
Sanidhya, J., Mazumder, A., & Saumya, D. (2024) · International Journal of Drug Delivery Technology · doi:10.25258/ijddt.14.2.80 · Cited by 1
“39 It has been observed that both elderly individuals and individuals with neurodegenerative diseases have a decrease in the diversity of their gut microbiota.”
BackgroundMicrobiome engineering in human health
Zhang, B., Zhou, Z., Yang, M., & Chen, P. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-22348-8.00001-5
Research Progress on the Relationship between Gut Microbiome and Parkinson’s Disease
力比奴尔·塞地尔丁, 克. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.14123217
Camacho, M. (2024) · Apollo (University of Cambridge) · doi:10.17863/cam.108869
Htoo, Z. W. (2022) · K-State Research Exchange (Kansas State University)
Glad, E. (2020) · Tampere University Institutional Repository (Tampere University)
Malattia di Parkinson e asse intestino-cervello: nuove prospettive sul microbiota intestinale
TUFILLI, V. (2024) · Electronic Theses and Dissertations Repository (University of Pisa)
Bi, R. (2025) · International journal of high school research · doi:10.36838/v7i12.87
Gitton-Quent, O. (2023) · theses.fr (ABES) · doi:10.70675/536e095fz1980z46a0za2daz41cbc1fb26b5
Zuo, T., Lu, Y., & Li, Y. P. (2025) · Springer handbooks · doi:10.1007/978-3-032-01636-2_37
Hu, Y., Chen, J.-S., Zhou, M., Huang, H., Zhou, Y.-F., Zhou, H.-Y., & Lv, Z. (2026) · Infectious Diseases of Poverty · doi:10.1186/s40249-026-01436-7
Ikkert, O. P., Gridina, M. M., Герасимчук, А. Л., & Petrov, V. A. (2026) · Opera medica et physiologica · doi:10.24412/2500-2295-2026-2-104-119
Zhao, X., McCarter, S. J., Gupta, V. K., Grant, K. M., Louis, E. K. S., Kantarci, K., Savica, R., Hill, M., Vuong, H. E., Staley, C. M., et al. (2026) · Frontiers in Microbiomes · doi:10.3389/frmbi.2026.1834726 · Cited by 1
Noor, U., Khan, I., Zheng, W.-F., Khan, I., & Li, S. (2026) · Ageing and Neurodegenerative Diseases · doi:10.20517/and.2026.06
Metadata
- Authors
- Minato, T., Maeda, T., Fujisawa, Y., Tsuji, H., Nomoto, K., Ohno, K., & Hirayama, M.
- Affiliations
- Nagoya University (JP)
- Iwate Medical University (JP)
- Yakult Central Institute (JP)
- Corresponding author
- Ohno, Kinji
- Hirayama, Masaaki
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2017-11-01
- Volume
- 12
- Issue
- 11
- Pages
- e0187307
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC5665539
- OpenAlex
- W2766355490
- Cited by
- 248
- References
- 54
- Citations by year
- 2026: 11 · 2025: 9 · 2024: 27 · 2023: 29 · 2022: 40 · 2021: 42 · 2020: 37 · 2019: 33 · 2018: 19 · 2017: 1
- FWCI
- 17.13
- Type
- journal article
- Language
- en
- Update notices
- expression_of_concern (2023-01-11)
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Japan Society for the Promotion of Science (JP) (24500458, 15H04840)
- Japan Agency for Medical Research and Development (JP) (17gm1010002h0002)
- Smoking Research Foundation (JP)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- Parkinson's disease, gut dysbiosis, gut microbiota, disease progression, Unified Parkinson's Disease Rating Scale, Bifidobacterium, Bacteroides fragilis, Atopobium, delusions and hallucinations, motor symptoms, disease progression biomarkers
- MeSH terms
- Gastrointestinal Microbiome, Aged, Bacteroides fragilis, Bifidobacterium, Clostridium, Female, Follow-Up Studies, Humans, Male, Middle Aged, Parkinson Disease, Colony Count, Microbial, Disease Progression, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.